Moderna
Breakthrough CMV vaccine offers hope to pregnant women
The vaccine, known as mRNA-1647, utilizes the same technology as Moderna's COVID-19 vaccines.
Health Ministry issues recommendation for Moderna COVID vaccine
Moderna says updated COVID vaccine is effective against newer variant
Moderna cancer vaccine with Merck's Keytruda delays return of deadly skin cancer
Moderna sues Pfizer and BioNTech over COVID-19 vaccine
Moderna said in a statement that Pfizer and BioNTech infringed on patents filed between 2010 and 2016 that covered its mRNA technology.
European Medicines Agency recommends Novavax add warning to their COVID-19 vaccine
The European Medicines Agency (EMA) is recommending that Novavax should start putting a warning label on their COVID-19 vaccines due to a small number of reported cases of heart inflammation.
COVID-19 booster shots are crucial, according to a Yale study
New study by Yale, UNC, shows that peak antibody levels achieved by getting vaccinated with an mRNA vaccine exceed those gained from natural infection.
CDC recommends Moderna's COVID vaccine for children 6 months-5 years
President Joe Biden's administration plans to roll out the vaccines to the under-5 age groups as early as next week.
Moderna files for US authorization of COVID shot for kids under 6
Moderna released trial data in March showing that its vaccine was safe and generated a similar immune response in young children as for adults.
Moderna recalls thousands of COVID vaccine doses in Europe
No safety issues have been identified, Moderna said about the lots that were distributed in Norway, Poland, Portugal, Spain and Sweden in January.
FDA green lights second COVID-19 booster shot for older Americans
Pfizer and BioNTech originally asked for the next booster doses to be authorized for people 65 and older in a submission citing data collected in Israel.
Phase I trial begins for Moderna's mRNA HIV vaccine
Since AIDS was first identified, over 36 million deaths have been attributed to it worldwide.
Omicron: UKHSA finds boosters provide 95% protection against death
For Moderna, effectiveness against hospitalization was 90-95% up to 9 weeks after the booster.
Pfizer CEO: COVID-19 will continue to circulate for many years
Bourla along with Moderna CEO Stéphane Bancel said last week that they are preparing a booster that will treat the newly-introduced Omicron variant.